ArticleBMC women's health2026
Factors influencing fear of cancer recurrence in breast cancer survivors: a multicenter cross-sectional study.
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeFear of cancer recurrence (FCR) is a prevalent psychological concern among breast cancer survivors, and identifying influencing factors is crucial for designing effective interventions. We aimed to investigate the relationship of FCR with sociodemographic characteristics, clinical features, physical and psychological symptoms, and social support among survivors of breast cancer.
methodsA cross-sectional study performed between November 2024, and January 2025. 387 potential participants were screened using convenience sampling. Fear of cancer recurrence, symptoms, and social support were assessed using the FCR Inventory-Short Form (FCRI-SF), the Memorial Symptom Assessment Scale (MSAS), and the Social Support Rating Scale (SSRS), respectively. Factors influencing FCR in survivors of breast cancer were determined using multiple linear regression.
resultsThe findings revealed that age < 40 years (B = 3.505, p = 0.012), severe medical burden (B = 5.079, p < 0.001), tumor stage III (B = 4.309, p = 0.018), cancer diagnosis time of 6-12 months (B = 2.174, p = 0.014), and chemotherapy (B = 2.077, p = 0.031) were significantly associated with higher FCR. Endocrine therapy was positively associated with FCR scores, although this association did not reach statistical significance (B = 2.300, p = 0.054). Among the psychological factors, worrying (B = 2.213, p < 0.001) and feeling nervous (B = 0.880, p = 0.006) were significantly associated with higher FCR. Among the physical factors, "I do not look like myself" (B = 0.796, p = 0.010) and lack of energy (B = 0.662, p = 0.018) were also significantly associated with higher FCR.
conclusionsFCR in this population is influenced by age, medical burden, cancer stage, duration of cancer diagnosis, treatment methods, and physical and psychological symptoms. Although social support was not significant in this study, its potential role, as reported in previous literature, warrants further attention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.